Roche hires new inflammation and virology head
This article was originally published in Scrip
Roche has appointed Jacques Banchereau head of its inflammation and virology R&D unit. Mr Banchereau will oversee R&D in autoimmune and respiratory diseases as rheumatoid arthritis and chronic obstructive pulmonary disease as well as in hepatitis, HIV, influenza and other infectious diseases. He will relocate to the Roche's R&D site in Nutley, New Jersey where the company's inflammation and virology unit is headquartered. He also will serve as Roche Nutley's Chief Scientific Officer. After working for Schering-Plough for 15 years, Mr Banchereau founded and was director of the Baylor Institute for Immunology Research in Dallas, Texas.